Balance Sheet And ProfitabilityEight consecutive quarters of positive EBITDA and about $71 million in net cash provide a financial cushion to support restructuring and execution of growth initiatives.
Cost Savings And Margin RecoveryPlanned exits of underperforming lines are expected to generate $8 million to $15 million in annual recurring savings, which should improve gross margins and SG&A leverage.
Portfolio OptimizationTransformation 2.0's exit from low-margin categories sharpens focus on wipes, diapers, and personal care, enabling more targeted marketing and simpler supply chain execution.